1st Circuit Affirms Dismissal Of All But 1 Fabrazyme Shortage Claim
BOSTON — The First Circuit U.S. Court of Appeals on May 23 said only one plaintiff in two class actions pleaded an injury claim from a shortage of the drug Fabrazyme...To view the full article, register now.
Already a subscriber? Click here to view full article